Does J2791 require prior authorization?

No, J2791 does not require prior authorization (high confidence). Code is covered without prior authorization.

What is the Medicare reimbursement rate for J2791?

Medicare facility rate: N/A. Non-facility rate: N/A. Work RVU: 0.00.

HCPCS/CPT

No Prior Auth Required

Code is covered without prior authorization (high confidence)

Work RVU

0.00

Facility

N/A

Non-Facility

N/A

Claims should reference and be supported by LCD L34580 and follow the billing/coding guidelines in this article; specific documentation requirements (e.g., medical records, prior authorization) are those detailed in LCD L34580.
Signed and dated office visit records and operative reports are required; all services ordered or rendered to Medicare beneficiaries must be signed.
For services requiring a referring/ordering physician, the referring/ordering physician's name and NPI must be reported on the claim.
The patient's medical record must include the ordering provider's assessment related to the patient's complaint for that visit and relevant medical history.

Billing and coding for intravenous immunoglobulin (IVIG) should follow the Local Coverage Determination (LCD) L34580 and the billing/coding guidelines in this article as a complement to that LCD.
IVIG is covered when the product is eligible under a Medicare benefit category, is reasonable and necessary for diagnosis or treatment per Social Security Act §1862(a)(1)(A), and meets all other applicable Medicare statutory and regulatory requirements and related LCD/Policy Article rules.
IVIG may be covered only when dispensed and billed to Medicare by the same entity that actually dispenses the drug to the Medicare beneficiary and that entity is licensed to dispense drugs in the state where it is physically located.
Treatment is indicated for Primary Immune Thrombocytopenia (ITP) when there is severe ITP with bleeding symptoms.
Treatment is indicated for adults with platelet count <= 30 x10^9/L, especially if risk factors for bleeding are present.
Treatment may be indicated for patients (adult or child) in preparation for procedures or surgery with a risk of bleeding.

CGS-L38268, Immune Thrombocytopenia (ITP) Therapy

J15

PALMETTO-JJ-L34580, Intravenous Immunoglobulin (IVIG)

PALMETTO-JM-L34580, Intravenous Immunoglobulin(IVIG)

A56718, Billing and Coding: Intravenous Immunoglobulin (IVIG)

A57160, Billing and Coding: Immune Thrombocytopenia (ITP) Therapy

Ask Verity about documentation requirements, denial risks, or coverage in your state.